The global lidocaine ointment market is expected to exhibit a CAGR of 7.7% during the forecast period. Due to the increasing approval of new drug for lidocaine ointment formulation. For instance, in ...

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their ...

The Alembic Pharma stock rose in early trade today after the firm announced its joint venture Aleor Dermaceuticals received approval from USFDA for Lidocaine Ointment USP, 5%. The ointment is used for ...

Mumbai: Alembic Pharmaceuticals Limited (Alembic) today announced that its wholly-owned subsidiary, Aleor Dermaceuticals Limited (Aleor) has received final approval from the US Food & Drug ...

Anesthesia is an important part of modern medicine. It’s hard to grasp how in the past people underwent surgeries without numbing their sensations first. Luckily, in the 21 st century, we have a ...

Dublin, Jan. 16, 2023 (GLOBE NEWSWIRE) -- The "Lidocaine Ointment Market, by Formulation, by Age Group, by Application, by Distribution Channel, by Region - Size, Share, Outlook, and Opportunity ...

Alembic Pharmaceuticals Limited on Tuesday has announced that its wholly owned subsidiary, Aleor Dermaceuticals Limited (Aleor) has received final approval from the US Food & Drug Administration ...